Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth.

Botton T, Puissant A, Cheli Y, Tomic T, Giuliano S, Fajas L, Deckert M, Ortonne JP, Bertolotto C, Tartare-Deckert S, Ballotti R, Rocchi S.

Cell Death Differ. 2011 Jan;18(1):109-21. doi: 10.1038/cdd.2010.75. Epub 2010 Jul 2.

2.

In vitro and in vivo anti-melanoma effects of ciglitazone.

Botton T, Puissant A, Bahadoran P, Annicotte JS, Fajas L, Ortonne JP, Gozzerino G, Zamoum T, Tartare-Deckert S, Bertolotto C, Ballotti R, Rocchi S.

J Invest Dermatol. 2009 May;129(5):1208-18. doi: 10.1038/jid.2008.346. Epub 2009 Jan 29.

3.

PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.

Grabacka M, Placha W, Urbanska K, Laidler P, Płonka PM, Reiss K.

Pigment Cell Melanoma Res. 2008 Jun;21(3):388-96. doi: 10.1111/j.1755-148X.2008.00460.x. Epub 2008 Apr 26.

4.

Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray.

Villareal MO, Han J, Ikuta K, Isoda H.

J Dermatol Sci. 2012 Jul;67(1):26-36. doi: 10.1016/j.jdermsci.2012.04.005. Epub 2012 Apr 19.

PMID:
22564683
5.

PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.

He S, Li CG, Slobbe L, Glover A, Marshall E, Baguley BC, Eccles MR.

Melanoma Res. 2011 Feb;21(1):24-34. doi: 10.1097/CMR.0b013e328341c7e0.

PMID:
21164369
6.

Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Keenen B, Qi H, Saladi SV, Yeung M, de la Serna IL.

Oncogene. 2010 Jan 7;29(1):81-92. doi: 10.1038/onc.2009.304. Epub 2009 Sep 28.

7.

The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Kawakami A, Fisher DE.

Lab Invest. 2017 Jun;97(6):649-656. doi: 10.1038/labinvest.2017.9. Epub 2017 Mar 6. Review.

PMID:
28263292
8.

A genomic screen identifies TYRO3 as a MITF regulator in melanoma.

Zhu S, Wurdak H, Wang Y, Galkin A, Tao H, Li J, Lyssiotis CA, Yan F, Tu BP, Miraglia L, Walker J, Sun F, Orth A, Schultz PG, Wu X.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17025-30. doi: 10.1073/pnas.0909292106. Epub 2009 Sep 23.

9.

MITF suppression by CH5552074 inhibits cell growth in melanoma cells.

Aida S, Sonobe Y, Yuhki M, Sakata K, Fujii T, Sakamoto H, Mizuno T.

Cancer Chemother Pharmacol. 2017 Jun;79(6):1187-1193. doi: 10.1007/s00280-017-3317-6. Epub 2017 Apr 26.

PMID:
28447210
10.

Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.

Hertzman Johansson C, Azimi A, Frostvik Stolt M, Shojaee S, Wiberg H, Grafström E, Hansson J, Egyházi Brage S.

Melanoma Res. 2013 Oct;23(5):360-5. doi: 10.1097/CMR.0b013e328362f9cd.

PMID:
23921446
11.

Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.

Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D.

Cancer Res. 2008 May 1;68(9):3124-32. doi: 10.1158/0008-5472.CAN-07-6622.

12.

Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.

Feige E, Yokoyama S, Levy C, Khaled M, Igras V, Lin RJ, Lee S, Widlund HR, Granter SR, Kung AL, Fisher DE.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E924-33. doi: 10.1073/pnas.1106351108. Epub 2011 Sep 26.

13.

Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.

Kido K, Sumimoto H, Asada S, Okada SM, Yaguchi T, Kawamura N, Miyagishi M, Saida T, Kawakami Y.

Cancer Sci. 2009 Oct;100(10):1863-9. doi: 10.1111/j.1349-7006.2009.01266.x. Epub 2009 Jun 29.

14.

Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.

Goodall J, Carreira S, Denat L, Kobi D, Davidson I, Nuciforo P, Sturm RA, Larue L, Goding CR.

Cancer Res. 2008 Oct 1;68(19):7788-94. doi: 10.1158/0008-5472.CAN-08-1053.

15.

GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.

Javelaud D, Alexaki VI, Pierrat MJ, Hoek KS, Dennler S, Van Kempen L, Bertolotto C, Ballotti R, Saule S, Delmas V, Mauviel A.

Pigment Cell Melanoma Res. 2011 Oct;24(5):932-43. doi: 10.1111/j.1755-148X.2011.00893.x. Epub 2011 Aug 18.

PMID:
21801332
16.

Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.

Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Bertolotto C, Virolle T, Barbry P, Pouysségur J, Ponzio G, Ballotti R.

J Cell Biol. 2005 Jul 4;170(1):49-59. Epub 2005 Jun 27.

17.
18.

Inhibition of Mek 1/2 kinase activity and stimulation of melanogenesis by 5,7-dimethoxycoumarin treatment of melanoma cells.

Alesiani D, Cicconi R, Mattei M, Bei R, Canini A.

Int J Oncol. 2009 Jun;34(6):1727-35.

PMID:
19424591
19.

Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.

Fernández-Barral A, Orgaz JL, Baquero P, Ali Z, Moreno A, Tiana M, Gómez V, Riveiro-Falkenbach E, Cañadas C, Zazo S, Bertolotto C, Davidson I, Rodríguez-Peralto JL, Palmero I, Rojo F, Jensen LD, del Peso L, Jiménez B.

Neoplasia. 2014 Jun;16(6):529-42. doi: 10.1016/j.neo.2014.06.001. Epub 2014 Jul 13.

20.

Regulation of MITF stability by the USP13 deubiquitinase.

Zhao X, Fiske B, Kawakami A, Li J, Fisher DE.

Nat Commun. 2011 Aug 2;2:414. doi: 10.1038/ncomms1421.

PMID:
21811243

Supplemental Content

Support Center